Location History:
- Burlingame, CA (US) (2020)
- Emeryville, CA (US) (2022)
Company Filing History:
Years Active: 2020-2025
Title: The Innovative Contributions of Kyle Jacoby
Introduction
Kyle Jacoby is a notable inventor based in Burlingame, CA (US). He has made significant contributions to the field of genomic modification and cancer treatment. With a total of 7 patents, his work is recognized for its impact on therapeutic approaches in medicine.
Latest Patents
Among his latest patents, Jacoby has developed methods for performing GUIDE-Seq on primary human T cells. These methods are designed to identify the effects of genomic modification with high accuracy, making them suitable for validating therapeutic T-cell engineering approaches. Additionally, he has created compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy. This innovative approach utilizes a neoTCR based cell therapy with a CD8 expression construct to enhance cancer treatment.
Career Highlights
Throughout his career, Kyle Jacoby has worked with several prominent companies, including Pact Pharma, Inc. and Adoc Ssf, LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in his field.
Collaborations
Jacoby has collaborated with talented individuals such as Alex Franzusoff and Barbara Sennino, who have played important roles in his professional journey.
Conclusion
Kyle Jacoby's innovative work in genomic modification and cancer treatment showcases his dedication to advancing medical science. His contributions continue to influence therapeutic strategies and improve patient outcomes.